Prediction: This Will Be Micron's Stock Price at the End of 2027 (Hint: It's Well Over $1,000)

Micron is benefiting from surging AI-driven memory demand, with management saying it has capacity for only half to two-thirds of medium-term demand and HBM TAM projected to grow from $35 billion in 2025 to $100 billion by 2028. The article argues this supply-demand imbalance supports pricing power and estimates EPS of $102.58 in fiscal 2027, rising to $133.35 in a stronger-demand scenario, implying a potential share price around $1,480 versus current levels. The piece is constructive on MU, though it also flags the cyclical risk that new supply could eventually drive memory prices lower.

Analysis

The market is increasingly treating memory like a duration asset tied to AI capex, but the real equity upside is less about peak pricing and more about how long Micron can stay under-earned relative to demand. The key second-order effect is that hyperscalers are now underwriting multi-year memory inventory commitments to protect AI cluster deployment, which can flatten the usual inventory bust phase and extend the cycle longer than historical analogs. That does not eliminate cyclicality; it just pushes the inflection point further out and makes near-term earnings revisions still biased upward.

The broader supply-chain winner is not just MU, but also any equipment and substrate vendors exposed to incremental fab buildouts, while NVIDIA gets a subtle tailwind from better availability of HBM for high-end training systems. The underappreciated risk is that the current shortage may induce over-ordering and double ordering by large buyers, which can make reported demand look more durable than end demand really is. If that happens, the setup becomes more fragile in 12-24 months as the new fabs ramp and customer inventories normalize.

Consensus appears to be underpricing how long the capacity deficit can persist, but overpricing the permanence of elevated margins. The market is likely still in the early-to-middle innings of the AI memory supercycle, which supports further multiple stability, but once supply response catches up, the valuation compression can be violent because earnings are procyclical and capital intensity is rising. The right mental model is not a straight-line rerating; it is a window of upward estimate revisions followed by a sharp reset when lead times and customer bookings roll over.

Key Decisions for Investors

• Stay long MU into the next 1-2 quarters, but prefer call spreads over outright equity: e.g., buy 12-18 month MU call spreads financed partly by selling upside 20-30% above spot to capture continued earnings revisions while limiting exposure if the cycle mean-reverts early.
• Pair long MU / short a basket of memory-adjacent capex beneficiaries with lower pricing power if you want cleaner alpha from the scarcity trade; use tight risk controls because the thesis breaks if HBM pricing starts to decelerate before fab supply arrives.
• Add NVDA on weakness only if AI memory availability remains constrained: more HBM supply supports system shipments and cluster rollouts, but if MU lead times shorten abruptly, NVDA can benefit from easier deployment rather than scarcity premium—watch for confirmation in supply chain checks over the next 1-2 quarters.
• Avoid chasing high-beta momentum entries after sharp gap-ups; instead, scale on post-earnings pullbacks when forward estimates are being revised up but implied volatility remains elevated, which typically improves reward-to-risk for cyclical semis.
• Set a 12-24 month exit discipline: if channel checks show memory lead times normalizing and customer inventory days starting to rise, reduce MU aggressively regardless of trailing earnings strength, since the stock can de-rate faster than EPS falls.